| Dr Timothy L Gess, MD | |
|
1501 Hawthorne St, Alexandria, MN 56308 | |
| (320) 762-2166 | |
| (320) 762-8898 |
| Full Name | Dr Timothy L Gess |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1501 Hawthorne St, Alexandria, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083708671 | NPI | - | NPPES |
| 0829344 | Other | MN | MEDICA |
| 1000172 | Other | MN | PREFERRED ONE |
| 61164GE | Other | MN | BC/BS OF MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 20870 (Minnesota) | Primary |
| Entity Name | Alexandria Eye Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932167772 PECOS PAC ID: 0143327031 Enrollment ID: O20070530000293 |
News Archive
Data from the independent KYOTO HEART study, presented recently at the European Society of Cardiology (ESC) Congress in Barcelona, Spain, and published online in the European Heart Journal demonstrated the addition of the angiotensin receptor blocker (ARB) Diovan (valsartan) to a non-ARB-based treatment regimen for high blood pressure provided a significant 45% relative risk reduction in cardiovascular events(1) including stroke, compared to conventional non-ARB treatment regimen.(1)
GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.
A new understanding of how anesthesia and anesthesia-like states are controlled in the brain opens the door to possible new future treatments of various states of loss of consciousness, such as reversible coma, according to Hebrew University of Jerusalem scientists.
Since the onset of the AIDS pandemic more than three decades ago, researchers from the lab and physicians in the clinic have been working toward one shared goal: an AIDS-free world. This week, a conference hosted by the journals Cell and The Lancet brought leading researchers and clinicians together to discuss recent findings that could bring hope to the estimated 35 million people world-wide who live with HIV.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy L Gess, MD 1501 Hawthorne St, Alexandria, MN 56308 Ph: (320) 762-2166 | Dr Timothy L Gess, MD 1501 Hawthorne St, Alexandria, MN 56308 Ph: (320) 762-2166 |
News Archive
Data from the independent KYOTO HEART study, presented recently at the European Society of Cardiology (ESC) Congress in Barcelona, Spain, and published online in the European Heart Journal demonstrated the addition of the angiotensin receptor blocker (ARB) Diovan (valsartan) to a non-ARB-based treatment regimen for high blood pressure provided a significant 45% relative risk reduction in cardiovascular events(1) including stroke, compared to conventional non-ARB treatment regimen.(1)
GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.
A new understanding of how anesthesia and anesthesia-like states are controlled in the brain opens the door to possible new future treatments of various states of loss of consciousness, such as reversible coma, according to Hebrew University of Jerusalem scientists.
Since the onset of the AIDS pandemic more than three decades ago, researchers from the lab and physicians in the clinic have been working toward one shared goal: an AIDS-free world. This week, a conference hosted by the journals Cell and The Lancet brought leading researchers and clinicians together to discuss recent findings that could bring hope to the estimated 35 million people world-wide who live with HIV.
› Verified 5 days ago
Dr. Kent Arthur Carlson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3401 S Broadway, Alexandria, MN 56308 Phone: 320-759-2020 Fax: 320-759-2424 | |
Dr. Deborah Gess Ristvedt, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2600 Jefferson St Ste 200, Alexandria, MN 56308 Phone: 320-335-0953 Fax: 320-762-8898 |